Atlas Trials

Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to Lenalidomide

Clinical trial NCT01166113 · COMPLETED

Trial details

NCT number
NCT01166113
Sponsor
Fondazione EMN Italy Onlus
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2010-07-01
Primary completion
2011-06-01
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.